Sponsor Pipeline

Outpace Bio, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07030907 A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian… Ovarian Cancer Recurrent Recruiting
NCT07664735 A Phase 1 Study to Evaluate the Safety and Efficacy of OPB-201 in Recurrent Endometrial… Endometrial Cancer Recurrent Not Yet Recruiting
Disease Areas
Ovarian Cancer (2) Endometrial Cancer (1)
Get alerts when Outpace Bio, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free